Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders

Journal of Inherited Metabolic Disease

Volumn 33, Issue 6, 2010, Pages 803-809

  De Grandis, Elisa ^a,c,e   Serrano, Mercedes ^a,e   Pérez Dueñas, Belén ^a,e   Ormazábal, Aida ^a,e   Montero, Raquel ^a,e   Veneselli, Edvige ^c   Pineda, Mercè ^a,e   González, Verónica ^a,e   Sanmartí, Francesc ^a,e   Fons, Carmen ^a,e   Sans, Anna ^a,e   Cormand, Bru ^d,e   Puelles, Luis ^b,e   Alonso, Antonia ^b,e   Campistol, Jaime ^a,e   Artuch, Rafael ^a,e   García Cazorla, Angels ^a,e  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF BARCELONA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPA; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL SULFATE; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; BIOGENIC AMINE; BIOPTERIN; HOMOVANILLIC ACID; NEOPTERIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE 2; TPH2 PROTEIN, HUMAN; TRYPTOPHAN HYDROXYLASE;

ADOLESCENT; ARTICLE; CEREBELLUM HYPOPLASIA; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; INBORN ERROR OF METABOLISM; LEUKODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NEUROTRANSMISSION; PRESCHOOL CHILD; RETT SYNDROME; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCHOOL CHILD; CASE CONTROL STUDY; CEREBROSPINAL FLUID; DEVELOPMENTAL DISORDER; GENETICS; INFANT; METABOLISM; NEWBORN; NUCLEOTIDE SEQUENCE;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; INFANT; INFANT, NEWBORN; MALE; NERVOUS SYSTEM DISEASES; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

EID: 79952565987     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9200-9     Document Type: Article

References (19)

1. Airaksinen E, Tuomisto L, Riikonen R (1992) The concentrations of GABA, 5-HIAA and HVA in the cerebrospinal fluid of children with infantile spasms and the effects of ACTH treatment. Brain Dev 14:386-390 (Pubitemid 23057657)
2. Alenina N, Kiric D, Todiras M et al. (2009) Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Nat Acad Sci USA 105:10332-10337
3. Assmann B, Kohler M, Hoffman G, Heales S, Surtees R (2002) Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia. Pediatr Res 52:91-94 (Pubitemid 34665956)
4. Duarte S, Sanmarti F, Gonzalez V et al. (2008) Cerebrospinal fluid pterins and neurotransmitters in early severe epileptic encephalopathies. Brain Dev 30:106-111 (Pubitemid 351179581)
5. García-Cazorla A, Serrano M, Pérez-Dueñas B et al. (2007) Secondary abnormalities of neurotransmitters in infant with neurological disorders. Dev Med Child Neurol 49:740-744 (Pubitemid 47456448)
6. García-Cazorla A, Duarte S, Serrano M et al. (2008) Mitochondrial diseases mimicking neurotransmitter defects. Mitochondrion 8:273-278
7. Herlenius E, Lagercrantz H (2001) Neurotransmitters and neuromodulators during early human development. Early Hum Dev 65:21-37 (Pubitemid 32743368)
8. Hyland K, Surtees RA, Heales SJ, Bowron A, Howells DW, Smith I (1993) Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr Res 34:10-14 (Pubitemid 23177751)
9. Kölker S, Sauer SW, Hoffmann GF, Müller I, Morath MA, Okun JG (2008) Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism. J Inherit Metab Dis 31:194-204
10. Langlais PJ, Wardlow ML, Yamamoto H (1991) Changes in CSF neurotransmitters in infantile spasms. Pediatr Neurol 7:440-445
11. Naumann M, Gotz M, Reiners K, Lange KW, Riederer P (1996) Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5HIIA levels as evidence of impaired serotoninergic metabolism. J Neural Transm 103:1083-1091 (Pubitemid 26383838)
12. Ohno Y, Hibino H, Lossin C, Inanobe A, Kurachi Y (2007) Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors. Brain Res 1178:44-51 (Pubitemid 47625356)
13. Ormazabal A, García-Cazorla A, Fernandez Y, Fernandez-Alvarez E, Campistol J, Artuch R (2005) HLPC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterins. J Neurosci Methods 142:153-158 (Pubitemid 40138040)
14. Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ (2001) Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry 50:783-791 (Pubitemid 33086766)
15. Pons R (2009) The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism. J Inherit Metab Dis 32:321-332
16. Ramaekers VT, Senderek J, Häusler M et al (2001) A novel developmental syndrome responsive to 5-hydroxytryptophan and carbidopa. Mol Genet Metab 73:179-187 (Pubitemid 32550156)
17. Van Der Heyden JC, RotteveelJJ, Wevers RA (2003) Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism. Eur J Paediatr Neurol 7(1):31-37 (Pubitemid 36284841)
18. Walitza S, Renner TJ, Dempfle A et al. (2005) Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry 10:1126-1132 (Pubitemid 43251103)
19. Zhang X, Gainetdinov RR, Beaulieu JM et al. (2005) Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45:11-16 (Pubitemid 40075345)